Raydiant Oximetry, Inc.

Raydiant Oximetry, Inc. is a clinical-stage medical device company founded in 2015, dedicated to developing innovative fetal monitoring technology to improve outcomes for mothers and babies during childbirth. The company aims to reduce maternal and neonatal morbidity and mortality, as well as the number of emergency Cesarean sections caused by inaccurate fetal distress detection. The flagship product, Lumerah™, is a non-invasive fetal pulse oximeter that measures fetal arterial blood oxygen saturation using patented optical sensing technology. This device addresses the limitations of traditional monitoring methods, providing more accurate data on fetal oxygenation. By doing so, Lumerah™ seeks to lower emergency C-section rates and decrease healthcare costs associated with childbirth. Raydiant Oximetry is supported by significant funding and partnerships, including grants from the Bill & Melinda Gates Foundation and collaborations with GE HealthCare. The team consists of experienced professionals from various fields, including medicine, science, and engineering, all focused on advancing maternal and fetal health. Their technology is primarily used by healthcare providers in labor and delivery settings, enhancing clinical decision-making and patient safety.

• Employees 27
• Founded 2016
• Annual Revenue $3000000
• Total Funding $18735855